Mayflower Financial Advisors’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

Mayflower Financial Advisors’s Portfolio IDNA Stock Details IDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-27,742	Closed	-$648K	–	350
2023 Q2	$648K	Sell	27,742 -6,594	-19%	-$158K	0.08%	172
2023 Q1	$799K	Buy	34,336 +12,584	+58%	+$315K	0.11%	152
2022 Q4	$547K	Sell	21,752 -1,601	-7%	-$43K	0.08%	181
2022 Q3	$616K	Sell	23,353 -5,623	-19%	-$174K	0.1%	149
2022 Q2	$837K	Sell	28,976 -45	-0.2%	-$1.34K	0.13%	123
2022 Q1	$1M	Buy	29,021 +7,132	+33%	+$252K	0.13%	112
2021 Q4	$959K	Buy	21,889 +3,122	+17%	+$148K	0.13%	116
2021 Q3	$924K	Buy	18,767 +2,566	+16%	+$134K	0.12%	114
2021 Q2	$843K	Buy	16,201 +595	+4%	+$27.9K	0.12%	121
2021 Q1	$713K	Buy	+15,606	New	+$762K	0.11%	129

Other funds holding IDNA

WBG

Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

IWC

Integrated Wealth Concepts Waltham, Massachusetts $12.5B AUM 18.49% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Mayflower Financial Advisors's IDNA Position: Q3 2023 in Review

Mayflower Financial Advisors sold out of iShares Genomics Immunology and Healthcare ETF (IDNA) in Q3 2023, closing a stake of 27,742 shares — an estimated $648K sold.

Mayflower Financial Advisors first reported a position in IDNA in Q1 2021 and held it in 10 quarters. The position peaked at $1M in Q1 2022. 66 funds tracked by Wall St. Rank hold IDNA as of Q3 2023.

Mayflower Financial Advisors reported no remaining iShares Genomics Immunology and Healthcare ETF position as of Q3 2023 after selling out during the quarter.
Mayflower Financial Advisors sold 27,742 iShares Genomics Immunology and Healthcare ETF shares in Q3 2023, an estimated $648K.
Mayflower Financial Advisors first reported a position in iShares Genomics Immunology and Healthcare ETF in Q1 2021 and held it in 10 quarters.
Mayflower Financial Advisors's iShares Genomics Immunology and Healthcare ETF position peaked at $1M in Q1 2022.
66 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q3 2023.

Based on Mayflower Financial Advisors's 13F filing for Q3 2023, filed 12 Oct 2023.